Published on
May 6, 2025
FDA Publishes Final Guidance On Reporting Listed Drug Amounts
By Howard Sklamberg and Sam Williams, Arnold & Porter On Feb. 6, 2024, the U.S. FDA issued a final guidance, Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act, intended to assist registrants of drug …
Source:
Clinical Supply Leader
-
Pending
